Information for "Stage Ib examine regarding individuals using metastatic castrateresistant cancer of prostate addressed with different sequencing regimens associated with atezolizumab along with sipuleucelT"
From EECH Central
Basic information
Display title | Stage Ib examine regarding individuals using metastatic castrateresistant cancer of prostate addressed with different sequencing regimens associated with atezolizumab along with sipuleucelT |
Default sort key | Stage Ib examine regarding individuals using metastatic castrateresistant cancer of prostate addressed with different sequencing regimens associated with atezolizumab along with sipuleucelT |
Page length (in bytes) | 3,468 |
Page ID | 1326674 |
Page content language | English (en) |
Page content model | wikitext |
Indexing by robots | Allowed |
Number of redirects to this page | 0 |
Page protection
Edit | Allow all users (infinite) |
Move | Allow all users (infinite) |
Edit history
Page creator | Ramieway1 (Talk | contribs) |
Date of page creation | 10:51, 1 April 2024 |
Latest editor | Ramieway1 (Talk | contribs) |
Date of latest edit | 10:51, 1 April 2024 |
Total number of edits | 1 |
Total number of distinct authors | 1 |
Recent number of edits (within past 90 days) | 1 |
Recent number of distinct authors | 1 |